AI-generated summary
This narrative review summarizes evidence on orthokeratology, which uses overnight contact lenses to correct vision during the day, for slowing myopia progression. The authors report that OK studies showed reduced axial growth, discuss proposed mechanisms and lens designs, and describe adverse events such as corneal staining and microbial keratitis. They also report additive effects with low-concentration atropine and early findings with repeated low-level red light, with further research on rebound and safety needed.
- Limits stated in the abstract
- The abstract does not report the number of studies or participants, and describes the review as narrative, with evidence for combination therapies and red light described as early.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ovid.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Myopia, Repeated low-level red light, Red light therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.